Consumer discretionary ( NYSEARCA: XLY) distribution and retail and consumer durables and apparel are the industries with ...
Morgan Stanley analyst Michael Ulz maintained a Hold rating on Alnylam Pharma (ALNY – Research Report) today and set a price target of $284.00. The company’s shares closed yesterday at $264.89.
Morgan Stanley analyst Michael Ulz maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $120.00. The company’s shares closed yesterday at ...
Mike Wilson, Morgan Stanley CIO, joins 'Power Lunch' to discuss investing in the European markets, the tech trade and the ...
Mike Wilson, Morgan Stanley CIO and chief U.S. equity strategist, joins 'Squawk Box' to discuss the latest market trends, why ...
What Happened: The Chief U.S. Equity Strategist and CIO of Morgan Stanley, Mike Wilson, predicted weak stock returns for the S&P 500 in the next 3 to 6 months. He pointed out that the “equity ...
Investors looking for havens from tariff strain should lean toward goods-oriented companies with stronger pricing power, says Morgan Stanley’s Mike Wilson.
That’s according to a team at Morgan Stanley led by chief U.S. stock-market strategist Mike Wilson, who told clients that its conviction in quality stocks has increased of late amid rising rates.
"A stronger dollar is likely to add to a recurring phenomenon into earnings season — an increase in dispersion of earnings per share (EPS) revisions," Morgan Stanley analyst Mike Wilson wrote in ...
RBC Capital analyst Matthew Hedberg maintained a Sector Perform rating and raised the price target from $240 to $260 on Jan. 3, 2025. This analyst has an accuracy rate of 74%. Morgan Stanley ...
Another analyst, Mike McGovern from Bank of America ... more than 85,000 stores across North America. On January 13, Morgan Stanley analyst Brian Nowak upgraded the price target on CART shares ...
"The dollar is incredibly sensitive to the tariff outlook right now," Kyle Chapman, FX markets analyst at Ballinger ... To that point, Morgan Stanley strategist Michael Zezas and economist Michael ...